These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 30019644)

  • 41. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
    Alam MS; Lee DU
    Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New pyrimidines and triazolopyrimidines as antiproliferative and antioxidants with cyclooxygenase-1/2 inhibitory potential.
    Omar AM; Abd El Razik HA; Hazzaa AA; El-Attar MA; El Demellawy MA; Abdel Wahab AE; El Hawash SA
    Future Med Chem; 2019 Jul; 11(13):1583-1603. PubMed ID: 31469327
    [No Abstract]   [Full Text] [Related]  

  • 43. Novel Antitubercular Agents: Design, Synthesis, Molecular Dynamic and Biological Studies of Pyrazole - 1,2,4-Triazole Conjugates.
    Ajin KA; Arun Kumar S; Singh M; Akshatha HS; Bhagyalalitha M; Pujar KG; Sumana MN; Chandrashekar VM; Bidye D; Pujar GV
    Chem Biodivers; 2023 Nov; 20(11):e202300971. PubMed ID: 37882429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors.
    Suresh A; Srinivasarao S; Agnieszka N; Ewa AK; Alvala M; Lherbet C; Chandra Sekhar KVG
    Chem Biol Drug Des; 2018 Jun; 91(6):1078-1086. PubMed ID: 29063733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold.
    Wang T; Tang Y; Yang Y; An Q; Sang Z; Yang T; Liu P; Zhang T; Deng Y; Luo Y
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2084-2090. PubMed ID: 29748048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-Lung Cancer Activities of 1,2,3-Triazole Curcumin Derivatives via Regulation of the MAPK/NF-κB/STAT3 Signaling Pathways.
    Zhi TX; Liu KQ; Cai KY; Zhao YC; Li ZW; Wang X; He XH; Sun XY
    ChemMedChem; 2022 Feb; 17(3):e202100676. PubMed ID: 34773680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
    Sajja Y; Vanguru S; Jilla L; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4292-5. PubMed ID: 27476139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New pyrimidine-benzoxazole/benzimidazole hybrids: Synthesis, antioxidant, cytotoxic activity, in vitro cyclooxygenase and phospholipase A2-V inhibition.
    Abdelgawad MA; Bakr RB; Ahmad W; Al-Sanea MM; Elshemy HAH
    Bioorg Chem; 2019 Nov; 92():103218. PubMed ID: 31536956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies.
    Rana M; Arif R; Khan FI; Maurya V; Singh R; Faizan MI; Yasmeen S; Dar SH; Alam R; Sahu A; Ahmad T; Rahisuddin
    Bioorg Chem; 2021 Mar; 108():104665. PubMed ID: 33571809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New bithiazolyl hydrazones: Novel synthesis, characterization and antitubercular evaluation.
    Bhalerao MB; Dhumal ST; Deshmukh AR; Nawale LU; Khedkar V; Sarkar D; Mane RA
    Bioorg Med Chem Lett; 2017 Jan; 27(2):288-294. PubMed ID: 27914801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
    Modi P; Patel S; Chhabria M
    Bioorg Chem; 2019 Jun; 87():240-251. PubMed ID: 30908967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A click chemistry approach for the synthesis of mono and bis aryloxy linked coumarinyl triazoles as anti-tubercular agents.
    Anand A; Naik RJ; Revankar HM; Kulkarni MV; Dixit SR; Joshi SD
    Eur J Med Chem; 2015 Nov; 105():194-207. PubMed ID: 26491982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clubbed triazoles: a novel approach to antitubercular drugs.
    Shiradkar M; Suresh Kumar GV; Dasari V; Tatikonda S; Akula KC; Shah R
    Eur J Med Chem; 2007 Jun; 42(6):807-16. PubMed ID: 17239490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, structural, multitargeted molecular docking analysis of anti-cancer, anti-tubercular, DNA interactions of benzotriazole based macrocyclic ligand.
    Pon Matheswari P; Ilavarasi Jeyamalar J; Iruthayaraj A; Ravindran Durai Nayagam B
    Bioorg Chem; 2024 Jun; 147():107361. PubMed ID: 38613924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
    Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation.
    Jiang Y; Qian A; Li Y
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900040. PubMed ID: 31106443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of novel Schiff bases and azol-β-lactam derivatives starting from morpholine and thiomorpholine and investigation of their antitubercular, antiurease activity, acethylcolinesterase inhibition effect and antioxidant capacity.
    Cebeci YU; Bayrak H; Şirin Y
    Bioorg Chem; 2019 Jul; 88():102928. PubMed ID: 31005785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles.
    Reddyrajula R; Dalimba U
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126846. PubMed ID: 31839540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives.
    Banu S; Bollu R; Nagarapu L; Nanubolu JB; Yogeswari P; Sriram D; Gunda SK; Vardhan D
    Chem Biol Drug Des; 2018 Jul; 92(1):1315-1323. PubMed ID: 29624868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 1,2,3-Triazole Tagged 3H-Pyrano[2,3-d]pyrimidine-6-carboxylate Derivatives: Synthesis, in Vitro Cytotoxicity, Molecular Docking and DNA Interaction Studies.
    Boda SK; Pishka V; Lakshmi PVA; Chinde S; Grover P
    Chem Biodivers; 2018 Jun; 15(6):e18000101. PubMed ID: 29660245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.